Zhanling International LTD 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Zhanling International Ltd. reports continued development-stage operations with no revenue, significant accumulated deficit, and reliance on capital raises and director loans for funding.
OTC.Pink
Zhanling International Ltd. reported increased net losses and a significant accumulated deficit for the quarter ended November 30, 2025, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
Zhanling International Ltd. reported an increased net loss for the quarter ended August 31, 2025, alongside a significant accumulated deficit and a going concern warning, despite converting payables to equity.
OTC.Pink
Zhanling International Ltd reports ongoing losses and a stockholders' deficit in its Q3 2025 report, casting significant doubt on its ability to continue as a going concern.
OTC.Pink
Zhanling International's latest quarterly report reveals increased losses and ongoing concerns about the company's ability to continue as a going concern.
OTC.Pink
Zhanling International reports a net loss for the three months ended August 31, 2024, with ongoing concerns about its ability to continue as a going concern.
OTC.Pink
Zhanling International reports no revenue and a net loss for Q1 2024, raising concerns about its ability to continue as a going concern.